XML 88 R77.htm IDEA: XBRL DOCUMENT v3.24.2
COMMITMENTS AND CONTINGENCIES - Narrative (Details)
$ in Thousands
 3 Months Ended 6 Months Ended
Dec. 06, 2022
USD ($)
payment
Jun. 30, 2024
USD ($)
liability
Jun. 30, 2024
USD ($)
liability
Jun. 30, 2023
USD ($)
Jan. 20, 2021
USD ($)
Jul. 29, 2019
USD ($)
Loss Contingencies [Line Items]            
Payment for contingent consideration     $ 11,923 $ 0    
Arkis            
Loss Contingencies [Line Items]            
Contingent consideration, estimated fair value           $ 25,500
Contingent consideration           13,100
Arkis | Development Milestones            
Loss Contingencies [Line Items]            
Contingent consideration, estimated fair value           10,000
Arkis | Commercial Sales Milestones            
Loss Contingencies [Line Items]            
Contingent consideration, estimated fair value           $ 15,500
Derma Sciences            
Loss Contingencies [Line Items]            
Number of contingent liabilities remaining | liability   1 1      
Contingent consideration, maximum undiscounted payment amount   $ 3,000 $ 3,000      
Derma Sciences | BioD Earnout Payments and Medihoney Earnout Payments            
Loss Contingencies [Line Items]            
Payment for contingent consideration     $ 33,300      
ACell, Inc.            
Loss Contingencies [Line Items]            
Contingent consideration         $ 23,900  
Number of contingent liabilities remaining | liability   1 1      
Contingent consideration, maximum undiscounted payment amount         $ 100,000  
Surgical Innovation Associates, Inc.            
Loss Contingencies [Line Items]            
Contingent consideration, maximum undiscounted payment amount $ 90,000          
Number of contingent liabilities | payment 2          
Surgical Innovation Associates, Inc. | Revenue Based Performance Milestones            
Loss Contingencies [Line Items]            
Contingent consideration, estimated fair value $ 32,600          
Payment for contingent consideration   $ 12,400        
Contingent consideration, maximum undiscounted payment amount 50,000          
Surgical Innovation Associates, Inc. | FDA Approval Of Premarket Approval            
Loss Contingencies [Line Items]            
Contingent consideration, estimated fair value 25,000          
Contingent consideration, maximum undiscounted payment amount $ 40,000